{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:18:57Z","timestamp":1777526337568,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21fk0210077"],"award-info":[{"award-number":["JP21fk0210077"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21fk0210047"],"award-info":[{"award-number":["JP21fk0210047"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21fk0210058"],"award-info":[{"award-number":["JP21fk0210058"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K17018"],"award-info":[{"award-number":["20K17018"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s12328-021-01459-7","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T15:06:30Z","timestamp":1623251190000},"page":"1431-1436","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A case of immune checkpoint inhibitor-related colitis with a distinctive endoscopic finding of colonic pseudolipomatosis"],"prefix":"10.1007","volume":"14","author":[{"given":"Tatsushi","family":"Naito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuto","family":"Nosaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuto","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Ofuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetaka","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ohtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsushi","family":"Hiramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamotsu","family":"Ishizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3160-3555","authenticated-orcid":false,"given":"Yasunari","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,9]]},"reference":[{"key":"1459_CR1","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1093\/ibd\/izy104","volume":"24","author":"Y Wang","year":"2018","unstructured":"Wang Y, Abu-Sbeih H, Mao E, et al. Endoscopic and histologic features of immune checkpoint inhibitor-related colitis. Inflam Bowel Dis. 2018;24:1695\u2013705.","journal-title":"Inflam Bowel Dis"},{"key":"1459_CR2","doi-asserted-by":"publisher","first-page":"e000278","DOI":"10.1136\/esmoopen-2017-000278","volume":"3","author":"MHG Foppen","year":"2018","unstructured":"Foppen MHG, Rozeman EA, van Wilpe S, et al. Immune checkpoint inhibition-related colitis: Symptoms, endoscopic features, histology and response to management. ESMO Open. 2018;3:e000278.","journal-title":"ESMO Open."},{"key":"1459_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4291\/wjgp.v10.i2.17","volume":"10","author":"T Nishida","year":"2019","unstructured":"Nishida T, Iijima H, Adachi S. Immune checkpoint inhibitor-induced diarrhea\/colitis: endoscopic and pathologic findings. World J Gastrointest Pathophysiol. 2019;10:17\u201328.","journal-title":"World J Gastrointest Pathophysiol"},{"key":"1459_CR4","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/ajcp\/84.5.575","volume":"84","author":"DC Snover","year":"1985","unstructured":"Snover DC, Sandstad J, Hutton S. Mucosal pseudolipomatosis of the colon. Am J Clin Pathol. 1985;84:575\u201380.","journal-title":"Am J Clin Pathol"},{"key":"1459_CR5","first-page":"90","volume":"32","author":"F Ers\u00f6z","year":"2016","unstructured":"Ers\u00f6z F, Toros AB, \u00c7akar E, et al. Colonic mucosal pseudolipomatosis: are we aware of it? Ulus Cerrahi Derg. 2016;32:90\u20132.","journal-title":"Ulus Cerrahi Derg"},{"key":"1459_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40425-018-0346-6","volume":"6","author":"Y Wang","year":"2018","unstructured":"Wang Y, Abu-Sbeih H, Mao E, et al. Immune-checkpoint inhibitor-induced diarrhea colitis patients adv malig retrospective review at md anderson. J Immunother Cancer. 2018;6:37.","journal-title":"J Immunother Cancer"},{"key":"1459_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.12998\/wjcc.v7.i4.405","volume":"7","author":"A Som","year":"2019","unstructured":"Som A, Mandaliya R, Alsaadi D, et al. Immune checkpoint inhibitor-induced colitis: a comprehensive review. World J Clin Cases. 2019;7:405\u201318.","journal-title":"World J Clin Cases"},{"key":"1459_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00428-017-2267-z","volume":"472","author":"N Assarzadegan","year":"2018","unstructured":"Assarzadegan N, Montgomery E, Anders RA. Immune checkpoint inhibitor colitis: the flip side of the wonder drugs. Virchows Arch. 2018;472:125\u201333.","journal-title":"Virchows Arch"},{"key":"1459_CR9","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1093\/ecco-jcc\/jjx081","volume":"11","author":"C Coutzac","year":"2017","unstructured":"Coutzac C, Adam J, Soularue E, et al. Colon immune-related adverse events: anti-CTLA-4 and anti-PD-1 blockade induce distinct immunopathological entities. J Crohns Colitis. 2017;11:1238\u201346.","journal-title":"J Crohns Colitis"},{"key":"1459_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000507579","volume":"5","author":"J Burla","year":"2020","unstructured":"Burla J, Bluemel S, Biedermann L, et al. Retrospective analysis of treatment and complications of immune checkpoint inhibitor-associated colitis: histological ulcerations as potential predictor for a steroid-refractory disease course. Inflamm Intest Dis. 2020;5:109\u201316.","journal-title":"Inflamm Intest Dis"},{"key":"1459_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41416-020-0882-y","volume":"123","author":"VTF Cheung","year":"2020","unstructured":"Cheung VTF, Gupta T, Olsson-Brown A, et al. Immune checkpoint inhibitor-related colitis assessment and prognosis: Can IBD scoring point the way? Br J Cancer. 2020;123:207\u201315.","journal-title":"Br J Cancer"},{"key":"1459_CR12","doi-asserted-by":"crossref","unstructured":"Wright AP, Piper MS, Bishu S, et al. Systematic review and case series: flexible sigmoidoscopy identifies most cases of checkpoint inhibitor-induced colitis. Systematic Review And Case Series. Aliment Pharmacol Ther. 2019;49:1474\u201383","DOI":"10.1111\/apt.15263"},{"key":"1459_CR13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12328-020-01276-4","volume":"14","author":"A Gallo","year":"2021","unstructured":"Gallo A, Talerico R, Novello L, et al. Collagenous colitis and atezolizumab therapy: an atypical case. Clin J Gastroenterol. 2021;14:165\u20139.","journal-title":"Clin J Gastroenterol"},{"key":"1459_CR14","first-page":"146","volume":"28","author":"MJ Magalh\u00e3es","year":"2015","unstructured":"Magalh\u00e3es MJ, Coelho A, Salgado M, et al. A rare case of colonic pseudolipomatosis. Ann Gastroenterol. 2015;28:146.","journal-title":"Ann Gastroenterol"},{"key":"1459_CR15","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.2169\/internalmedicine.0730-17","volume":"57","author":"M Iwamuro","year":"2018","unstructured":"Iwamuro M, Tanaka T, Kawabata T, et al. Pseudolipomatosis of the colon and cecum followed by pneumatosis intestinalis. Intern Med. 2018;57:2501\u20134.","journal-title":"Intern Med"},{"key":"1459_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s003840050031","volume":"11","author":"G Gagliardi","year":"1996","unstructured":"Gagliardi G, Thompson IW, Hershman MJ, et al. Pneumatosis coli: a proposed pathogenesis based on study of 25 cases and review of the literature. Int J Colorectal Dis. 1996;11:111\u20138.","journal-title":"Int J Colorectal Dis"},{"key":"1459_CR17","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1055\/s-2007-966652","volume":"39","author":"G Cammarota","year":"2007","unstructured":"Cammarota G, Cesaro P, Cazzato A, et al. Hydrogen peroxide-related colitis (previously known as \u201cpseudolipomatosis\u201d): a series of cases occurring in an epidemic pattern. Endoscopy. 2007;39:916\u20139.","journal-title":"Endoscopy"},{"key":"1459_CR18","doi-asserted-by":"crossref","unstructured":"Tang T, Abu-Sbeih H, Ma W, et al. Gastrointestinal injury related to antiangiogenesis cancer therapy. Clin Colorectal Cancer. 2020; 19:e117\u201323","DOI":"10.1016\/j.clcc.2020.03.002"},{"key":"1459_CR19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s12887-019-1732-z","volume":"19","author":"S Kunzmann","year":"2019","unstructured":"Kunzmann S, Ngyuen T, Stahl A, et al. Necrotizing enterocolitis after intravitreal bevacizumab in an infant with Incontinentia Pigmenti\u2014a case report. BMC Pediatr. 2019;19:353.","journal-title":"BMC Pediatr"},{"key":"1459_CR20","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3109\/0284186X.2010.498430","volume":"50","author":"L Baandrup","year":"2011","unstructured":"Baandrup L, Hauggaard A, Winberg BH, et al. Neutropenic enterocolitis during first-line chemotherapy with carboplatin and etoposide in small cell lung cancer. Acta Oncol. 2011;50:465\u20137.","journal-title":"Acta Oncol"},{"key":"1459_CR21","doi-asserted-by":"crossref","first-page":"749789","DOI":"10.1155\/2010\/749789","volume":"2010","author":"V Masciullo","year":"2010","unstructured":"Masciullo V, Mainenti S, Lorusso D, et al. Lethal Clostridium difficile colitis associated with paclitaxel and carboplatin chemotherapy in ovarian carcinoma: Case report and review of the literature. Obstet Gynecol Int. 2010;2010:749789.","journal-title":"Obstet Gynecol Int"},{"key":"1459_CR22","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.2214\/AJR.12.8782","volume":"199","author":"AB Shinagare","year":"2012","unstructured":"Shinagare AB, Howard SA, Krajewski KM, et al. Pneumatosis intestinalis and bowel perforation associated with molecular targeted therapy: an emerging problem and the role of radiologists in its management. AJR Am J Roentgenol. 2012;199:1259\u201365.","journal-title":"AJR Am J Roentgenol"},{"key":"1459_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10637-007-9094-z","volume":"26","author":"TR Asmis","year":"2008","unstructured":"Asmis TR, Chung KY, Teitcher JB, et al. Pneumatosis intestinalis: a variant of bevacizumab related perforation possibly associated with chemotherapy related GI toxicity. Invest New Drugs. 2008;26:95\u20136.","journal-title":"Invest New Drugs"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-021-01459-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-021-01459-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-021-01459-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T13:52:34Z","timestamp":1725198754000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-021-01459-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,9]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1459"],"URL":"https:\/\/doi.org\/10.1007\/s12328-021-01459-7","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,9]]},"assertion":[{"value":"19 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human rights"}},{"value":"Informed consent was obtained from the patient for being included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}